Can Anamorelin Relieve Cancer Cachexia? How long does it take to see results

Cancer cachexia is a complex syndrome characterized by significant weight loss, muscle wasting, and metabolic disorders. It is common in patients with solid tumors such as advanced lung cancer, gastric cancer, and pancreatic cancer. It is one of the important reasons for the increase in cancer mortality. Anamorelin (Anamorelin), as an oral ghrelin receptor agonist, has been widely studied to alleviate the symptoms of cancer cachexia. Its mechanism of action is not limited to stimulating appetite, but also involves improving metabolic status, promoting protein synthesis, and regulating growth hormone release.

In practical applications, anamorelin can effectively increase patients' appetite levels and alleviate symptoms such as weight loss and lean body mass. Although its direct improvement in muscle strength was not significant in some studies, it still shows clinical value in enhancing patients' ability to eat, maintaining nutritional status, and improving overall quality of life. For cancer patients, weight stabilization and appetite restoration alone are key to delaying the progression of the disease.

Generally, patients may gradually experience changes such as increased appetite and slight weight gain within the first two to four weeks after starting to take anamorelin. The specific onset time is affected by factors such as the patient's basal metabolic state, primary tumor type, disease progression rate, etc., and is also closely related to whether nutritional intervention, radiotherapy, chemotherapy and other treatments are combined. Some studies have pointed out that after continuous use for 4 weeks or more, anamulin is more effective in increasing body weight and improving food intake. Therefore, taking it regularly and combining it with dietary management can enhance the effect of the drug.

It is worth noting that anamorelin is not a treatment for the tumor itself, but is part of supportive care. Its ultimate goal is to improve the nutritional status and quality of life of cancer patients, delay the state of exhaustion caused by cachexia, and thus assist the smooth progress of other treatment strategies.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/